These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8618266)

  • 21. Prolonged muscle weakness after neuromuscular blockade in the intensive care unit.
    Raps EC; Bird SJ; Hansen-Flaschen J
    Crit Care Clin; 1994 Oct; 10(4):799-813. PubMed ID: 8000927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma cholinesterase activity and neuromuscular paralysis by succinylcholine.
    Kelemen MH; Volle RL
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):477-83. PubMed ID: 5916749
    [No Abstract]   [Full Text] [Related]  

  • 23. Clindamycin-induced neuromuscular blockade.
    al Ahdal O; Bevan DR
    Can J Anaesth; 1995 Jul; 42(7):614-7. PubMed ID: 7553999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma cholinesterase activity in infants.
    Vassallo SA; Goudsouzian NG
    Can J Anaesth; 1994 Jul; 41(7):654-5. PubMed ID: 8087915
    [No Abstract]   [Full Text] [Related]  

  • 25. Sedation and paralysis.
    Piriyapatsom A; Bittner EA; Hines J; Schmidt UH
    Respir Care; 2013 Jun; 58(6):1024-37. PubMed ID: 23709198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can residual paralysis be avoided?: A critical appraisal of the use of sugammadex.
    Esteves S
    Eur J Anaesthesiol; 2015 Oct; 32(10):663-5. PubMed ID: 26322661
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuromuscular blockade in adult intensive care.
    Topulos GP
    New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral neuropathy and neuromuscular blockade presenting as prolonged respiratory paralysis following critical illness.
    Heckmatt JZ; Pitt MC; Kirkham F
    Neuropediatrics; 1993 Jun; 24(3):123-5. PubMed ID: 8395027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precurarization--a hazard to the patient?
    Engbaek J; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1984 Feb; 28(1):61-2. PubMed ID: 6143465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adequate confirmation of recovery from neuromuscular blockade: what are the obstacles?
    Caruso L; Urdaneta F
    Can J Anaesth; 2014 Jan; 61(1):82. PubMed ID: 24203502
    [No Abstract]   [Full Text] [Related]  

  • 32. Unexpected prolonged neuromuscular block after mivacurium: a case report.
    Hemadri M; Purva M; Traykova V
    Med Princ Pract; 2002; 11(1):50-2. PubMed ID: 12116697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anesthesia related muscle paralysis in renal failure.
    Sirotzky L; Lewis EJ
    Clin Nephrol; 1978 Jul; 10(1):38-42. PubMed ID: 359207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature.
    Watling SM; Dasta JF
    Crit Care Med; 1994 May; 22(5):884-93. PubMed ID: 7910130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromuscular monitoring, residual blockade, and reversal: time for re-evaluation of our clinical practice.
    Plaud B
    Can J Anaesth; 2013 Jul; 60(7):634-40. PubMed ID: 23661296
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuromuscular blockade due to gentamicin sulfate.
    Brownsberger RJ; Morrelli HF
    West J Med; 1988 Feb; 148(2):215. PubMed ID: 3348034
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of quinidine on plasma cholinesterase activity and succinylcholine neuromuscular blockade.
    Kambam JR; Franks JJ; Naukam R; Sastry BV
    Anesthesiology; 1987 Nov; 67(5):858-60. PubMed ID: 3674502
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages].
    Schuh FT
    Klin Anasthesiol Intensivther; 1980; 22():158-74. PubMed ID: 6108384
    [No Abstract]   [Full Text] [Related]  

  • 39. Importance of the level of paralysis recovery for a rapid antagonism of atracurium neuromuscular blockade with moderate doses of edrophonium.
    Hennart D; d'Hollander A; Plasman C; De Jonckheere M
    Anesthesiology; 1986 Mar; 64(3):384-7. PubMed ID: 3754099
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply: To PMID 23625545.
    Donati F
    Can J Anaesth; 2014 Jan; 61(1):83. PubMed ID: 24536097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.